New HIV prevention drug lenacapavir shows 100% efficacy

ScienceAlert — July 10, 2024, 08:00 AM UTC

Summary: A new HIV prevention drug, lenacapavir, showed 100% efficacy in a clinical trial in South Africa and Uganda. The trial included 5,000 young women, with none of the 2,134 women who received lenacapavir contracting HIV. The drug, administered twice yearly, offers hope for highly effective HIV prevention. The trial's success may lead to global adoption pending regulatory approvals and pricing considerations.

Full article

Article metrics

Significance6.3

Scale & Impact0.0

Positivity9.0

Credibility7.8

What is this?

This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.

My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.

Read more about how I calculate significance, or see today's top ranked news on the main page:

See today's news rankings

Timeline:

[4.4]
Biannual lenacapavir injection 100% effective in preventing HIV (News Karnataka)
99d 16h
Source
[5.1]
UNAIDS urges global access to new HIV drug Lenacapavir (Marketscreener.com)
102d 18h
Scores Source
[4.6]
Biannual Lenacapavir injection 100% effective against HIV (WION)
105d 18h
Source
[5.8]
Lenacapavir injection offers 100% HIV protection to young women (Hindustan Times)
106d 12h
Scores Source
[5.2]
HIV prevention drug lenacapavir safe and effective in trial (The East African)
107d 13h
Scores Source
[6.1]
HIV prevention injection successful in South Africa trial (AllAfrica - Top Africa News)
112d 16h
Scores Source